These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 8107816)

  • 21. Japan edges cautiously towards gene therapy.
    Nature; 1994 Jul; 370(6487):243. PubMed ID: 8035865
    [No Abstract]   [Full Text] [Related]  

  • 22. US bioethics panel poised to judge local review boards.
    Macilwain C
    Nature; 1996 Oct; 383(6600):466. PubMed ID: 8849708
    [No Abstract]   [Full Text] [Related]  

  • 23. NIH panel proposes guidelines for human gene therapy research.
    Med World News; 1984 Dec; 25(23):7. PubMed ID: 11645538
    [No Abstract]   [Full Text] [Related]  

  • 24. New rules for gene-transfer trials.
    Nelson RM
    IRB; 2001; 23(6):11. PubMed ID: 12737176
    [No Abstract]   [Full Text] [Related]  

  • 25. Government regulation of human gene therapy.
    Gage JL
    Jurimetrics; 1987; 27(2):200-18. PubMed ID: 11651978
    [No Abstract]   [Full Text] [Related]  

  • 26. Much more research to fall under IRB review.
    Maloney DM
    Hum Res Rep; 1999 Jul; 14(7):3. PubMed ID: 11658059
    [No Abstract]   [Full Text] [Related]  

  • 27. Safety boards must report their conclusions to IRBs.
    Maloney DM
    Hum Res Rep; 1999 Oct; 14(10):3. PubMed ID: 11658061
    [No Abstract]   [Full Text] [Related]  

  • 28. IRBs and research with human biological materials.
    Maloney DM
    Hum Res Rep; 1999 Jan; 14(1):2. PubMed ID: 11657556
    [No Abstract]   [Full Text] [Related]  

  • 29. Keeping faith in gene manipulation.
    Nature; 1996 Jul; 382(6588):191. PubMed ID: 8717027
    [No Abstract]   [Full Text] [Related]  

  • 30. Ethics debate heats up as gene therapy moves toward clinical trials.
    Med World News; 1984 Nov; 25(21):34, 36. PubMed ID: 11645570
    [No Abstract]   [Full Text] [Related]  

  • 31. Protection of human subjects.
    United States
    Code Fed Regul Shipping; 1982 Oct; Part 46, Sections 46.101 to 46.306():. PubMed ID: 11660819
    [No Abstract]   [Full Text] [Related]  

  • 32. IRBs and pharmaceutical company funding of research.
    Jellinek MS; Levine RJ
    IRB; 1982 Oct; 4(8):9-10. PubMed ID: 11651693
    [No Abstract]   [Full Text] [Related]  

  • 33. Commission says institutional review boards should change procedures now.
    Maloney DM
    Hum Res Rep; 1999 Jan; 14(1):1-2. PubMed ID: 11657555
    [No Abstract]   [Full Text] [Related]  

  • 34. National commission proposes numerous new regulations of institutional review boards.
    Maloney DM
    Hum Res Rep; 1998 Oct; 13(10):1-2. PubMed ID: 11657739
    [No Abstract]   [Full Text] [Related]  

  • 35. Plan to end genetics panel troubles EPA.
    Science; 1996 Aug; 273(5278):1035. PubMed ID: 11644823
    [No Abstract]   [Full Text] [Related]  

  • 36. Orkin-Motulsky panel calls for gene therapy basic research.
    Fox JL
    Gene Ther; 1996 Jan; 3(1):pre-1. PubMed ID: 11644882
    [No Abstract]   [Full Text] [Related]  

  • 37. US finally faces up to embryo research.
    Kleiner K
    New Sci; 1994 Feb; 141(1912):8. PubMed ID: 11656311
    [No Abstract]   [Full Text] [Related]  

  • 38. Proposed restrictions relaxed on research on mentally disabled.
    Macilwain C
    Nature; 1998 Oct; 395(6704):731. PubMed ID: 9796801
    [No Abstract]   [Full Text] [Related]  

  • 39. Gene therapists face double check.
    Swinbanks D
    Nature; 1994 May; 369(6475):5. PubMed ID: 8164738
    [No Abstract]   [Full Text] [Related]  

  • 40. Guidelines may boost gene therapy in Japan.
    Barker S
    Nature; 1995 Nov; 378(6555):327. PubMed ID: 7477360
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.